Year |
Citation |
Score |
2020 |
Rai G, Urban DJ, Mott BT, Hu X, Yang SM, Benavides GA, Johnson MS, Squadrito GL, Brimacombe KR, Lee TD, Cheff DM, Zhu H, Henderson MJ, Pohida K, Sulikowski GA, ... ... Hathaway HJ, et al. Pyrazole-Based Lactate Dehydrogenase (LDH) Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties. Journal of Medicinal Chemistry. PMID 32902275 DOI: 10.1021/Acs.Jmedchem.0C00916 |
0.309 |
|
2020 |
Sharma G, Hu C, Staquicini DI, Brigman JL, Liu M, Mauvais-Jarvis F, Pasqualini R, Arap W, Arterburn JB, Hathaway HJ, Prossnitz ER. Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes. Science Translational Medicine. 12. PMID 31996464 DOI: 10.1126/Scitranslmed.Aau5956 |
0.319 |
|
2019 |
Revankar CM, Bologa CG, Pepermans RA, Sharma G, Petrie WK, Alcon SN, Field AS, Ramesh C, Parker MA, Savchuk NP, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling. Cell Chemical Biology. PMID 31706983 DOI: 10.1016/J.Chembiol.2019.10.009 |
0.719 |
|
2019 |
Triplett KD, Pokhrel S, Castleman MJ, Daly SM, Elmore BO, Joyner JA, Sharma G, Herbert G, Campen MJ, Hathaway HJ, Prossnitz ER, Hall PR. GPER activation protects against epithelial barrier disruption by Staphylococcus aureus α-toxin. Scientific Reports. 9: 1343. PMID 30718654 DOI: 10.1038/S41598-018-37951-3 |
0.394 |
|
2017 |
Peretti AS, Dominguez D, Grimes MM, Hathaway HJ, Prossnitz ER, Rivera MR, Wandinger-Ness A, Kusewitt DF, Hudson LG. The R-enantiomer of ketorolac delays mammary tumor development in mouse mammary tumor virus-polyoma middle T antigen (MMTV-PyMT) mice. The American Journal of Pathology. PMID 29169987 DOI: 10.1016/J.Ajpath.2017.10.018 |
0.374 |
|
2017 |
Vreeland EC, Minser KE, Weldon CL, Gomez A, Karaulanov T, Hathaway HJ, Anderson WH, Nettles C, Huber DL, Paciotti G. Abstract 2859: Sensitive, specific detection of Her-2 positive tumors in mice using superparamagnetic relaxometry (SPMR) Cancer Research. 77: 2859-2859. DOI: 10.1158/1538-7445.Am2017-2859 |
0.316 |
|
2016 |
Lujan DA, Garcia S, Vanderhoof J, Sifuentes J, Brandt Y, Wu Y, Guo X, Mitchell T, Howard T, Hathaway HJ, Hartley RS. Cold-inducible RNA binding protein in mouse mammary gland development. Tissue & Cell. PMID 27837912 DOI: 10.1016/J.Tice.2016.10.004 |
0.407 |
|
2015 |
Prossnitz ER, Hathaway HJ. What have we learned about GPER function in physiology and disease from knockout mice? The Journal of Steroid Biochemistry and Molecular Biology. 153: 114-26. PMID 26189910 DOI: 10.1016/J.Jsbmb.2015.06.014 |
0.424 |
|
2014 |
Nayak TK, Ramesh C, Hathaway HJ, Norenberg JP, Arterburn JB, Prossnitz ER. GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding. Molecular Cancer Research : McR. 12: 1635-43. PMID 25030373 DOI: 10.1158/1541-7786.Mcr-14-0289 |
0.479 |
|
2014 |
Marjon NA, Hu C, Hathaway HJ, Prossnitz ER. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis. Molecular Cancer Research : McR. 12: 1644-54. PMID 25030371 DOI: 10.1158/1541-7786.Mcr-14-0128-T |
0.398 |
|
2014 |
Scaling AL, Prossnitz ER, Hathaway HJ. GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast. Hormones & Cancer. 5: 146-60. PMID 24718936 DOI: 10.1007/S12672-014-0174-1 |
0.717 |
|
2013 |
Petrie WK, Dennis MK, Hu C, Dai D, Arterburn JB, Smith HO, Hathaway HJ, Prossnitz ER. G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstetrics and Gynecology International. 2013: 472720. PMID 24379833 DOI: 10.1155/2013/472720 |
0.493 |
|
2013 |
Guo H, Hathaway H, Royce ME, Prossnitz ER, Miao Y. Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides. Bioorganic & Medicinal Chemistry Letters. 23: 5484-7. PMID 24018188 DOI: 10.1016/J.Bmcl.2013.08.075 |
0.365 |
|
2012 |
Guo X, Wu Y, Hathaway HJ, Hartley RS. Microenvironmental control of the breast cancer cell cycle. Anatomical Record (Hoboken, N.J. : 2007). 295: 553-62. PMID 22271550 DOI: 10.1002/Ar.22417 |
0.389 |
|
2012 |
Meyer MR, Amann K, Field AS, Hu C, Hathaway HJ, Kanagy NL, Walker MK, Barton M, Prossnitz ER. Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension. 59: 507-12. PMID 22203741 DOI: 10.1161/Hypertensionaha.111.184606 |
0.404 |
|
2011 |
Dennis MK, Field AS, Burai R, Ramesh C, Petrie WK, Bologa CG, Oprea TI, Yamaguchi Y, Hayashi S, Sklar LA, Hathaway HJ, Arterburn JB, Prossnitz ER. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. The Journal of Steroid Biochemistry and Molecular Biology. 127: 358-66. PMID 21782022 DOI: 10.1016/J.Jsbmb.2011.07.002 |
0.435 |
|
2011 |
Guo H, Lu J, Hathaway H, Royce ME, Prossnitz ER, Miao Y. Synthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides. Bioconjugate Chemistry. 22: 1682-9. PMID 21749045 DOI: 10.1021/Bc200252J |
0.369 |
|
2011 |
Wu Y, Guo X, Brandt Y, Hathaway HJ, Hartley RS. Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells. Breast Cancer Research and Treatment. 127: 397-406. PMID 20607601 DOI: 10.1007/S10549-010-1013-X |
0.368 |
|
2010 |
Nayak TK, Dennis MK, Ramesh C, Burai R, Atcher RW, Sklar LA, Norenberg JP, Hathaway HJ, Arterburn JB, Prossnitz ER. Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents. Acs Chemical Biology. 5: 681-90. PMID 20486699 DOI: 10.1021/Cb1000636 |
0.409 |
|
2010 |
Ramesh C, Nayak TK, Burai R, Dennis MK, Hathaway HJ, Sklar LA, Prossnitz ER, Arterburn JB. Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30. Journal of Medicinal Chemistry. 53: 1004-14. PMID 20041667 DOI: 10.1021/Jm9011802 |
0.439 |
|
2009 |
Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER. GPR30 predicts poor survival for ovarian cancer. Gynecologic Oncology. 114: 465-71. PMID 19501895 DOI: 10.1016/J.Ygyno.2009.05.015 |
0.444 |
|
2009 |
Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, et al. In vivo effects of a GPR30 antagonist. Nature Chemical Biology. 5: 421-7. PMID 19430488 DOI: 10.1038/Nchembio.168 |
0.715 |
|
2008 |
Nayak TK, Hathaway HJ, Ramesh C, Arterburn JB, Dai D, Sklar LA, Norenberg JP, Prossnitz ER. Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 978-86. PMID 18483091 DOI: 10.2967/Jnumed.107.048546 |
0.398 |
|
2008 |
Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annual Review of Physiology. 70: 165-90. PMID 18271749 DOI: 10.1146/Annurev.Physiol.70.113006.100518 |
0.46 |
|
2004 |
de la Cruz L, Steffgen K, Martin A, McGee C, Hathaway H. Apoptosis and involution in the mammary gland are altered in mice lacking a novel receptor, beta1,4-Galactosyltransferase I. Developmental Biology. 272: 286-309. PMID 15282149 DOI: 10.1016/J.Ydbio.2004.03.041 |
0.442 |
|
2003 |
Hathaway HJ. Cell surface beta1,4-galactosyltransferase function in mammary gland morphogenesis: insights from transgenic and knockout mouse models. Journal of Mammary Gland Biology and Neoplasia. 8: 421-33. PMID 14985638 DOI: 10.1023/B:Jomg.0000017429.47855.52 |
0.44 |
|
2003 |
Hathaway HJ, Evans SC, Dubois DH, Foote CI, Elder BH, Shur BD. Mutational analysis of the cytoplasmic domain of beta1,4-galactosyltransferase I: influence of phosphorylation on cell surface expression. Journal of Cell Science. 116: 4319-30. PMID 12966167 DOI: 10.1242/Jcs.00720 |
0.596 |
|
2002 |
Steffgen K, Dufraux K, Hathaway H. Enhanced branching morphogenesis in mammary glands of mice lacking cell surface beta1,4-galactosyltransferase. Developmental Biology. 244: 114-33. PMID 11900463 DOI: 10.1006/Dbio.2002.0599 |
0.384 |
|
1994 |
Youakim A, Hathaway HJ, Miller DJ, Gong X, Shur BD. Overexpressing sperm surface β1,4-galactosyltransferase in transgenic mice affects multiple aspects of sperm-egg interactions Journal of Cell Biology. 126: 1573-1583. PMID 8089187 DOI: 10.1083/Jcb.126.6.1573 |
0.589 |
|
1992 |
Hathaway HJ, Shur BD. Cell surface β1,4-galactosyltransferase functions during neural crest cell migration and neurulation in vivo Journal of Cell Biology. 117: 369-382. PMID 1560031 DOI: 10.1083/Jcb.117.2.369 |
0.628 |
|
1991 |
Hathaway HJ, Runyan RB, Khounlo S, Shur BD. Purification and characterization of avian β1,4 galactosyltransferase: Comparison with the mammalian enzyme Glycobiology. 1: 211-221. PMID 1823164 DOI: 10.1093/Glycob/1.2.211 |
0.679 |
|
1991 |
HATHAWAY HJ, BABIARZ BS. Galactosyltransferase Functions as a Cell Surface Receptor during Embryonic Development. Trends in Glycoscience and Glycotechnology. 3: 414-421. DOI: 10.4052/Tigg.3.414 |
0.731 |
|
1989 |
Hathaway HJ, Romagnano LC, Babiarz BS. Analysis of cell surface galactosyltransferase activity during mouse trophectodermal differentiation. Developmental Biology. 134: 351-61. PMID 2501126 DOI: 10.1016/0012-1606(89)90107-3 |
0.703 |
|
1988 |
Hathaway HJ, Babiarz BS. Developmental regulation of the monoclonally defined IIC3 antigen during primary and secondary trophoblast differentiation in vitro. Cell Differentiation. 24: 55-66. PMID 3409325 DOI: 10.1016/0045-6039(88)90086-3 |
0.708 |
|
1988 |
Babiarz BS, Donovan MJ, Hathaway HJ. The developmental pathology of maternally derived Thp fetuses. Teratology. 37: 353-64. PMID 3293259 DOI: 10.1002/Tera.1420370409 |
0.66 |
|
1988 |
Babiarz BS, Hathaway HJ. Hormonal control of the expression of antibody-defined lactosaminoglycans in the mouse uterus. Biology of Reproduction. 39: 699-706. PMID 3196800 DOI: 10.1095/Biolreprod39.3.699 |
0.689 |
|
1988 |
Hathaway HJ, Shur BD. Novel cell surface receptors during mammalian fertilization and development. Bioessays. 9: 153-158. PMID 3149196 DOI: 10.1002/Bies.950090504 |
0.65 |
|
1986 |
Babiarz BS, Hathaway HJ. Immunofluorescent localization of a monoclonally defined carbohydrate cell surface antigen (IIC3) during mouse development. Experimental Cell Research. 163: 221-32. PMID 3510886 DOI: 10.1016/0014-4827(86)90575-6 |
0.705 |
|
Show low-probability matches. |